间歇性禁食对心血管疾病危险因素影响的研究进展

doi:10.12114/j.issn.1007-9572.2021.00.330

中国全科医学 ›› 2022, Vol. 25 ›› Issue (01): 127-130.DOI: 10.12114/j.issn.1007-9572.2021.00.330

• 新进展 • 上一篇

间歇性禁食对心血管疾病危险因素影响的研究进展

崔艳如¹, 岑秋宇¹, 魏娟芳¹, 王文春², 张安仁^3,^*

1.610075　四川省成都市，成都中医药大学养生康复学院
2.610083　四川省成都市，西部战区总医院康复医学科
3.200434　上海市，同济大学附属上海市第四人民医院康复医学科

收稿日期:2021-09-03 修回日期:2021-10-28 出版日期:2022-01-05 发布日期:2021-12-29
通讯作者: 张安仁
基金资助:
国家自然科学基金面上项目(81973927)

Research Progress on the Influence of Intermittent Fasting on Cardiovascular Disease Risk Factors

CUI Yanru1，CEN Qiuyu1，WEI Juanfang1，WANG Wenchun2，ZHANG Anren3*

1.School of Health and Rehabilitation，Chengdu University of Traditional Chinese Medicine，Chengdu 610075，China
2.Department of Rehabilitation Medicine，the General Hospital of Western Theater Command，Chengdu 610083，China
3.Department of Rehabilitation Medicine，Shanghai Fourth People's Hospital Affiliated to Tongji University，Shanghai 200434，China
*Corresponding author：ZHANG Anren，Chief physician，Doctoral supervisor；E-mail：1518526780@qq.com

Received:2021-09-03 Revised:2021-10-28 Published:2022-01-05 Online:2021-12-29

分享到

1. PDF全文+完整参考文献.pdf(414KB)

摘要/Abstract

摘要： 近年来，我国心血管疾病的患病率和死亡率呈明显上升趋势，心血管疾病已成为危害我国居民健康的主要疾病。间歇性禁食（IF）作为一种周期性能量限制的饮食干预方式，已被证明有广泛的健康益处，有助于减轻体质量、改善葡萄糖调节、降低血压和血脂水平、抑制炎性反应等，进而延缓心血管疾病的发生与发展。目前，我国学者对IF在防治心血管疾病中的潜在作用关注不足。本文通过对IF对血脂异常、肥胖、糖尿病、高血压等心血管疾病危险因素的影响及其机制进行综述，旨在为心血管疾病的防治提供新思路。本研究发现IF在心血管疾病防治中具有潜在的应用前景，可用于防控心血管疾病发生的危险因素，其介导的代谢益处可能与激发"代谢转换"、增强白色脂肪褐变、促进自噬及重塑肠道菌群等有关。

关键词: 间歇性禁食, 心血管疾病, 危险因素, 热量限制, 综述

Abstract:

In recent years, the prevalence and mortality of cardiovascular diseases in China have shown a significant upward trend, cardiovascular disease has become a major disease endangering the health of Chinese residents. Intermittent fasting (IF) as a cyclical energy restriction dietary intervention has been proven to have a wide range of health benefits, which can reduce weight, improve glucose regulation, lower blood pressure and blood lipid levels, inhibit inflammation, so as to delay the occurrence and development of cardiovascular disease. Currently, researchers in China have paid insufficient attention to the potential role of IF in the prevention and treatment of cardiovascular diseases. This article reviews the effects and mechanisms of IF on cardiovascular disease risk factors such as dyslipidemia, obesity, diabetes and hypertension, in order to provide new ideas for the prevention and treatment of cardiovascular diseases. It is found that IF has potential application prospects in the prevention and treatment of cardiovascular diseases, which can be used to prevent and control the risk factors of cardiovascular disease, the IF-mediated metabolic benefits can be related to glucose-ketone body metabolic transformation, browning of white fat, autophagy pathway and remodeling of intestinal flora.

Key words: Intermittent fasting, Cardiovascular diseases, Risk factors, Caloric restriction, Review

中图分类号:

R459.3R54

崔艳如,岑秋宇,魏娟芳,等. 间歇性禁食对心血管疾病危险因素影响的研究进展[J]. 中国全科医学, 2022, 25(01): 127-130. DOI: 10.12114/j.issn.1007-9572.2021.00.330.

CUI Yanru, CEN Qiuyu, WEI Juanfang, WANG Wenchun, ZHANG Anren.

Research Progress on the Influence of Intermittent Fasting on Cardiovascular Disease Risk Factors [J]. Chinese General Practice, 2022, 25(01): 127-130.

参考文献

［1］SHEN C，GE J. Epidemic of cardiovascular disease in China：current perspective and prospects for the future［J］. Circulation，2018，138（4）：342-344. DOI：10.1161/CIRCULATIONAHA.118.033484.

［2］中国心血管健康与疾病报告编写组 . 中国心血管健康与疾病报告 2019 概要［J］. 中国循环杂志，2020，35（9）：833-854.DOI：10.3969/j.issn.1000-3614.2020.09.001.　

The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2019：an updated summary［J］. Chinese Circulation Journal，2020，35（9）：833-854. DOI：10.3969/j.issn.1000-3614.2020.09.001.

［3］ZHANG X，ZOU Q，ZHAO B，et al. Effects of alternate-day fasting，time-restricted fasting and intermittent energy restriction DSS-induced on colitis and behavioral disorders［J］. Redox Biol，2020，32（5）：101535. DOI：10.1016/j.redox.2020.101535.

［4］DECABO R，MATTSON M P. Effects of intermittent fasting on health，aging，and disease［J］. New Eng J Med，2019，381（26）：2541-2551. DOI：10.1056/NEJMra1905136.

［5］MATTSON M P，LONGO V D，HARVIE M. Impact of intermittent fasting on health and disease processes［J］. Ageing Res Rev，2017，39（10）：46-58. DOI：10.1016/j.arr.2016.10.005.

［6］白鑫，赵兴胜 . 25- 羟维生素 D 对心血管疾病相关危险因素的影响［J］. 内蒙古医学杂志，2021，53（2）：164-166. DOI：10.16096/J.cnki.nmgyxzz.2021.53.02.012.

［7］BROWNING J D，BAXTER J，SATAPATI S，et al. The effect of short-term fasting on liver and skeletal muscle lipid，glucose，and energy metabolism in healthy women and men［J］. J Lipid Res，2012，53（3）：577-586. DOI：10.1194/jlr.P020867.

［8］MATTSON M P，MOEHL K，GHENA N，et al. Intermittent metabolic switching，neuroplasticity and brain health［J］. Nat Rev Neurosci，2018，19（2）：63-80. DOI：10.1038/nrn.2017.156.

［9］VARADY K A，ROOHK D J，LOE Y C，et al. Effects of modified alternate-day fasting regimens on adipocyte size，triglyceride metabolism，and plasma adiponectin levels in mice［J］. J Lipid Res，2007，48（10）：2212-2219. DOI：10.1194/jlr.M700223-JLR200.

［10］WILSON R A，DEASY W，STATHIS C G，et al. Intermittent fasting with or without exercise prevents weight gain and improves lipids in diet-induced obese mice［J］. Nutrients，2018，10（3）：346. DOI：10.3390/nu10030346.

［11］HARVIE M N，PEGINGTON M，MATTSON M P，et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers：a randomized trial in young overweight women［J］. Int J Obes，2011，35（5）：714-727. DOI：10.1038/ijo.2010.171.

［12］LIU B，HUTCHISON A T，THOMPSON C H，et al. Effects of intermittent fasting or calorie restriction on markers of lipid metabolism in human skeletal muscle［J］. J Clin Endocrinol Metab，2021，106（3）：e1389-1399.

［13］MIYAMOTO J，OHUE-KITANO R，MUKOUYAMA H，et al. Ketone body receptor GPR43 regulates lipid metabolism under ketogenic conditions［J］. P Natl Acad Sci USA，2019，116（47）：23813-23821. DOI：10.1073/pnas.1912573116.

［14］RYCHTER A M，RATAJCZAK A E，ZAWADA A，et al. Nonsystematic review of diet and nutritional risk factors of cardiovascular disease in obesity［J］. Nutrients，2020，12（3）：814. DOI：10.3390/nu12030814.

［15］SAITO M，OKAMATSU-OGURA Y，MATSUSHITA M，et al. High incidence of metabolically active brown adipose tissue in healthy adult humans：effects of cold exposure and adiposity［J］. Diabetes，2009，58（7）：1526-1531.

［16］HATORI M，VOLLMERS C，ZARRINPAR A，et al. Timerestricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet［J］. Cell Metab，2012，15（6）：848-860. DOI：10.1016/j.cmet.2012.04.019.

［17］LI G，XIE C，LU S，et al. Intermittent fasting promotes white adipose browning and decreases obesity by shaping the gut microbiota［J］. Cell Metab，2017，26（4）：672-685. DOI：10.1016/j.cmet.2017.08.019.

［18］HANATANI S，MOTOSHIMA H，TAKAKI Y，et al. Acetate alters expression of genes involved in beige adipogenesis in 3T3-L1 cells and obese KK-Ay mice［J］. J Clin Biochem Nutr，2016，59（3）：207-214. DOI：10.3164/jcbn.16-23.

［19］VERGNES L，REUE K. Adaptive thermogenesis in white adipose tissue：is lactate the new brown（ing）［J］. Diabetes，2014，63（10）：3175-3176. DOI：10.2337/db14-0815.

［20］KIM K，KIM Y H，SON J E，et al. Intermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGFmediated alternative activation of macrophage［J］. Cell Res，2017，27（11）：1309-1326. DOI：10.1038/cr.2017.126.

［21］HATTING M，RINES A K，LUO C，et al. Adipose tissue CLK2 promotes energy expenditure during high-fat diet intermittent fasting［J］. Cell Metab，2017，25（2）：428-437. DOI：10.1016/j.cmet.2016.12.007.

［22］PARK J，SEO Y G，PAEK Y J，et al. Alternate-day fasting，obesity，and metabolic syndrome［J］. Metabolism，2020，111（10）：154336. DOI：10.1016/j.metabol.2020.154336.
［23］BARQUISSAU V，LÉGER B，BEUZELIN D，et al. Caloric restriction and diet-induced weight loss do not induce browning of human subcutaneous white adipose tissue in women and men with obesity［J］. Cell Rep，2018，22（4）：1079-1089. DOI：10.1016/j.celrep.2017.12.102.
［24］ALMOURANI R，CHINNAKOTLA B，PATEL R，et al. Diabetes and cardiovascular disease：an update［J］. Curr Diabetes Rep，2019，19（12）：161. DOI：10.1007/s11892-019-1239-x.
［25］SUTTON E F，BEYL R，EARLY K S，et al. Early time-restricted feeding improves insulin sensitivity，blood pressure，and oxidative stress even without weight loss in men with prediabetes［J］. Cell Metab，2018，27（6）：1212-1221. DOI：10.1016/j.cmet.2018.04.010.
［26］BELKACEMI L，SELSELET-ATTOU G，HUPKENS E，et al. Intermittent fasting modulation of the diabetic syndrome in streptozotocin-injected rats［J］. Int J Endocrinol，2012，2012（1）：962012. DOI：10.1155/2012/962012.
［27］WEI S，HAN R，ZHAO J，et al. Intermittent administration of a fasting-mimicking diet intervenes in diabetes progression，restores β cells and reconstructs gut microbiota in mice［J］. Nutr Metab，2018，15（11）：80. DOI：10.1186/s12986-018-0318-3.
［28］YANG J，LU C，KUO S，et al. Autophagy and its link to type ii diabetes mellitus［J］. BioMedicine，2017，7（2）：8. DOI：10.1051/bmdcn/2017070201.
［29］LIU H，JAVAHERI A，GODAR R J，et al. Intermittent fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway［J］. Autophagy，2017，13（11）：1952-1968. DOI：10.1080/15548627.2017.1368596.
［30］KOHLMAN-TRIGOBOFF D. Hypertension management in patients with vascular disease：an update.［J］. J Vasc Nurs，2016，34（3）：87-92. DOI：10.1016/j.jvn.2016.01.002.
［31］MAGER D E，WAN R，BROWN M，et al. Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats［J］. FASEB J，2006，20（6）：631-637. DOI：10.1096/fj.05-5263com.
［32］WILHELMI-DE-TOLEDO F，GRUNDLER F，BERGOUIGNAN A，et al. Safety，health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1 422 subjects［J］. PLoS One，2019，14（1）：e209353. DOI：10.1371/journal.pone.0209353.
［33］WAN R，WEIGAND L A，BATEMAN R，et al. Evidence that BDNF regulates heart rate by a mechanism involving increased brainstem parasympathetic neuron excitability［J］. J Neurochem，2014，129（4）：573-580. DOI：10.1111/jnc.12656.
［34］YANG T，SANTISTEBAN M M，RODRIGUEZ V，et al. Gut dysbiosis is linked to hypertension［J］. 2015，65（6）：1331-1340. DOI：10.1161/HYPERTENSIONAHA.115.05315.
［35］DURGAN D J，GANESH B P，COPE J L，et al. Role of the gut microbiome in obstructive sleep apnea-induced hypertension［J］. Hypertension，2016，67（2）：469-474. DOI：10.1161/HYPERTENSIONAHA.115.06672.
［36］LI J，ZHAO F，WANG Y，et al. Gut microbiota dysbiosis contributes to the development of hypertension［J］. Microbiome，2017，5（1）：14. DOI：10.1186/s40168-016-0222-x.
［37］KIM S，GOEL R，KUMAR A，et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure［J］. Clin Sci，2018，132（6）：701-718. DOI：10.1042/CS20180087.
［38］ADNAN S，NELSON J W，AJAMI N J，et al. Alterations in the gut microbiota can elicit hypertension in rats［J］. Physiol Genomics，2017，49（2）：96-104. DOI：10.1152/physiolgenomics.00081.2016.
［39］SHI H，ZHANG B，ABO-HAMZY T，et al. Restructuring the gut microbiota by intermittent fasting lowers blood pressure［J］. Circ Res，2021，128（9）：1240-1254. DOI：10.1161/CIRCRESAHA.120.318155.
［40］AVERY E G，BARTOLOMAEUS H，MAIFELD A，et al. The gut microbiome in hypertension：recent advances and future perspectives［J］. Circ Res，2021，128（7）：934-950. DOI：10.1161/CIRCRESAHA.121.318065.
［41］VERHAAR B J H，PRODAN A，NIEUWDORP M，et al. Gut microbiota in hypertension and atherosclerosis：a review［J］. Nutrients，2020，12（10）：2982. DOI：10.3390/nu12102982.
［42］KUMAR P，GOGULAMUDI V R，PERIASAMY R，et al. Inhibition of HDAC enhances STAT acetylation，blocks NF-κB，and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice［J］. Am J Physiol Renal，2017，313（3）：F781-795. DOI：10.1152/ajprenal.00166.2017.
［43］GOLIA E，LIMONGELLI G，NATALE F，et al. Inflammation and cardiovascular disease：from pathogenesis to therapeutic target［J］. Curr Atheroscler Rep，2014，16（9）：435. DOI：10.1007/s11883-014-0435-z.
［44］FARIS M A，KACIMI S，AL-KURD R A，et al. Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects［J］. Nutr Res，2012，32（12）：947-955. DOI：10.1016/j.nutres.2012.06.021.
［45］BHUTANI S，KLEMPEL M C，BERGER R A，et al. Improvements in coronary heart disease risk indicators by alternate-day fasting involve adipose tissue modulations［J］. Obesity，2010，18（11）：2152-2159. DOI：10.1038/oby.2010.54.
［46］KANG D R，YADAV D，KOH S B，et al. Impact of serum leptin to adiponectin ratio on regression of metabolic syndrome in high-risk individuals：the ARIRANG study［J］. Yonsei Med J，2017，58（2）：339-346. DOI：10.3349/ymj.2017.58.2.339.
［47］ŻELECHOWSKA P，BRZEZIŃŻSKA-BŁŻASZCZYK E，WIKTORSKA M，et al. Adipocytokines leptin and adiponectin function as mast cell activity modulators［J］. Immunology，2019，158（1）：3-18. DOI：10.1111/imm.13090.
［48］WAN R，AHMET I，BROWN M，et al. Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats［J］. J Nutr Biochem，2010，21（5）：413-417. DOI：10.1016/j.jnutbio.2009.01.020.

[1]	王旭, 魏戌, 朱立国, 冯天笑, 王志鹏, 师彬. 医工结合的中医手法治疗脊柱退行性疾病疗效机制研究：思路与前景[J]. 中国全科医学, 2023, 26(33): 4118-4124.
[2]	辛功恺, 丛欣, 袁磊, 程悦彤, 倪翠萍, 张巍巍, 張平平, 刘宇. 失智症老年人综合评估工具的研究进展[J]. 中国全科医学, 2023, 26(33): 4103-4109.
[3]	刘伟娜, 葛海燕, 马静, 曹琴英, 白星宇, 崔士芳, 乔彦霞. 脐血维生素A和维生素E水平与早产儿发生呼吸窘迫综合征的关系研究[J]. 中国全科医学, 2023, 26(33): 4152-4158.
[4]	张思宇, 周郁秋, 杜晓慧, 王正君. 精神病未治期及其早期干预的研究进展[J]. 中国全科医学, 2023, 26(33): 4110-4117.
[5]	李纪新, 邱林杰, 任燕, 王文茹, 李美洁, 张晋. 膳食炎症指数与超重和肥胖及腹型肥胖关系的Meta分析[J]. 中国全科医学, 2023, 26(32): 4089-4097.
[6]	马丽媛, 王增武, 樊静, 胡盛寿. 《中国心血管健康与疾病报告2022》要点解读[J]. 中国全科医学, 2023, 26(32): 3975-3994.
[7]	李雨荆, 晋一超, 陈醒, 嵇梦颖, 戴辉华. 服用他莫昔芬的乳腺癌患者宫腔镜检出子宫内膜病变的危险因素研究[J]. 中国全科医学, 2023, 26(32): 4026-4030.
[8]	孟江涛, 杨思宇, 孙蕾, 雷瑞宁, 赵晓霞. 弥散张量成像联合运动诱发电位评估脑梗死偏瘫患者运动功能预后价值的研究进展[J]. 中国全科医学, 2023, 26(32): 4098-4102.
[9]	王佳欣, 赵亚利. 国内外医疗团队合作评估工具系统综述[J]. 中国全科医学, 2023, 26(31): 3951-3962.
[10]	卫梦雨, 王佳佳, 张莹莹, 李春阳, 李建生. 阻塞性睡眠呼吸暂停患者报告结局测评工具研究现状分析[J]. 中国全科医学, 2023, 26(30): 3725-3733.
[11]	苑喜微, 南月敏. 线粒体融合蛋白2的结构和功能及其在肝脏疾病中作用机制的研究进展[J]. 中国全科医学, 2023, 26(30): 3841-3846.
[12]	肖雨倩, 白艳杰, 王岩, 陈淑颖, 陈丽敏, 孙可心, 万俊. 线粒体转移在脑卒中后认知障碍中的研究进展[J]. 中国全科医学, 2023, 26(30): 3833-3840.
[13]	刘煜, 岳婷, 杨东宇, 赵中亭, 杨吉勃, 朱田田. 自噬在类风湿关节炎发病机制中的研究进展[J]. 中国全科医学, 2023, 26(29): 3710-3714.
[14]	潘姚佳, 王为强, 易伟卓, 高兵, 傅方琳, 韩正, 孙梦, 董雅勤, 顾怀聪. 不同性别中年肥胖居民三酰甘油葡萄糖乘积指数与心血管疾病高危风险的关系研究[J]. 中国全科医学, 2023, 26(29): 3628-3635.
[15]	蒲瑜, 张吉翔, 董卫国. 铁死亡与炎症性肠病的研究进展[J]. 中国全科医学, 2023, 26(29): 3698-3703.

间歇性禁食对心血管疾病危险因素影响的研究进展

Research Progress on the Influence of Intermittent Fasting on Cardiovascular Disease Risk Factors

PDF

补充材料

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

留言